glp-1 agonist pharmacology Recent updates on agonists: Current advancements & challenges Frontiers | Mechanisms of action

"Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis"

Further research is warranted to explore long-term outcomes and optimize treatment protocols for this patient population

A meta-analysis

By no means are my updates complete or conclusive

This improvement is associated with a significant increase in Iba-1/Arg-1 positive microglia, reduced neuroinflammation, and inhibition of microglial activation

Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro